The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...

Despite its proven benefits, deworming remains underfunded and under-prioritized in Kenya. This is ironic because it is one ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Animal health leaders concerned about anthelmintics resistance are urging farmers reaching for alternatives to an established ...

Now in its 18th year, the 24-hour online fundraiser is set for Thursday, Feb. 13, with several lakes-area charities set to ...